Krystal Biotech Inc (KRYS)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

2100 WHARTON STREET PITTSBURGH, PA 15203

Krystal Biotech, Inc. operates as a biopharmaceutical company. The Company develops a proprietary gene therapy platform for the patients suffering from rare debilitating disorders. Krystal Biotech serves patients in the State of Pennsylvania.

Data based on most recent fiscal year report
Market Cap98.611 Million Shares Outstanding10.24 Million Avg Volume15.869 Thousand
1-Yr BETA vs S&P TR1.137 Current Ratio77.98 Quick Ratio77.98
View SEC Filings from KRYS instead.
Q2 2019 All Institutions Hedge Funds 1
To trade KRYS now:
Filers who had this stock in their top 10: 2 0 (0.0%)
13F Filers holding this stock: 73 18 (1.86%)
Aggregate 13F shares on 06/30/2019: 9.757 Million 3.963 Million
Aggregate 13F shares on 03/31/2019: 6.649 Million 2.322 Million
Percent change: 46.73% 70.64%
Funds creating new positions: 28 9
Funds Adding to an existing position: 26 6
Funds closing out their position: 11 4
Funds reducing their position: 14 2
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

 

Krystal Biotech Inc Chart by YCharts

Yahoo! Finance

finviz

Check out our reporting and analysis

Funds Holding KRYS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

88.7 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

JANNEY DANIEL

  • Director
 366,362 2019-08-29 1

RILEY ANTONY A CHIEF FINANCIAL OFFICER

  • Officer
 0 2019-06-01 2

GANGOLLI JULIAN S PRESIDENT, NORTH AMERICA

  • Officer
 106,548 2019-05-10 2

KRISHNAN KRISH S PRESIDENT AND CEO

  • Officer
  • Director
  • 10% Owner
 4,150,086 2018-10-18 1

KRISHNAN SUMA CHIEF OPERATING OFFICER

  • Officer
  • Director
  • 10% Owner
 4,150,086 2018-10-18 1

NORBY R DOUGLAS

  • Director
 0 2018-05-31 0

ROSSI DINO A

  • Director
 0 2018-05-31 0

SUN PHARMA (NETHERLANDS) B.V.

  • 10% Owner
 0 2017-09-19 0

GANORKAR KIRTI

  • Director
 0 2017-09-19 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

JANNEY DANIEL - Director see footnotes

2019-08-30 S 32,190 $46.18 d 366,362 366,362.00 indirect

JANNEY DANIEL - Director see footnotes

2019-08-29 S 55,794 $46.61 d 399,252 366,362.00 indirect

JANNEY DANIEL - Director see footnotes

2019-08-29 S 700 $47.50 d 398,552 366,362.00 indirect
Click here to report any possible errors with this stock listing.

Elevate your investments